investing-statsSEC Form 4 insider transactions

MDT · Medtronic plc

← all insiders

Electromedical & Electrotherapeutic Apparatus · Listed on NYSE

Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON

Open-market trades1
Distinct insiders1
Bought$0
Sold$257.9K
Net flow$-257.9K

Recent filings

How to read this

Filed
Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
Ticker
The issuer's stock symbol. Select it to open that company's insider-activity page.
Issuer
The company whose shares were traded.
Sector
The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
Insider
The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
Role
The insider's relationship to the company: director, officer, or 10% owner.
Code
SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
Side
Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
10b5-1
Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
Shares
Number of shares in this transaction.
Price
Reported price per share. Blank for grants, gifts, and other trades with no stated price.
Value
Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
Owned after
Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
Own Δ
How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
Co. Δ
Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
D/I
Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
Lag
Days from the trade date to the filing date (Form 4 is due within 2 business days).

Transaction codes

Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.

P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award or other acquisition pursuant to Rule 16b-3(d)
D
Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
F
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
M
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
G
Bona fide gift
C
Conversion of derivative security
X
Exercise of in-the-money or at-the-money derivative security
J
Other acquisition or disposition (describe transaction)
Recent Form 4 filings for MDT
FiledDate the Form 4 was filed with the SEC (due within 2 business days of the trade).InsiderRoleCodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S).SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼).SharesNumber of shares in this transaction.PriceReported price per share. Blank for trades with no stated price.ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ).Owned afterShares the insider held (directly or indirectly) immediately after this trade.Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable.Link to SEC filing
2026-08-24Marinaro MichaelOfficer (EVP, Pres MedSurg and Americas)F sell1,0840$92.30$100.1K116,336−0.9%−<0.01% (now <0.01%)filing
2026-08-04Blomquist Denise L.Officer (Chief Accounting Officer)A buy1,366 1,366 Ordinary Shares1,366filing
2026-08-04Blomquist Denise L.Officer (Chief Accounting Officer)A buy2,337 2,337 Ordinary Shares2,337filing
2026-08-04Blomquist Denise L.Officer (Chief Accounting Officer)A buy2,337016,998+16%+<0.01% (now <0.01%)filing
2026-08-04Blomquist Denise L.Officer (Chief Accounting Officer)F sell2120$85.39$18.1K14,661−1%−<0.01% (now <0.01%)filing
2026-08-04Walter Matthew R.Officer (SVP, Chief HR Officer)A buy40,973 40,973 Ordinary Shares40,973filing
2026-08-04Walter Matthew R.Officer (SVP, Chief HR Officer)A buy14,421 14,421 Ordinary Shares14,421filing
2026-08-04Walter Matthew R.Officer (SVP, Chief HR Officer)A buy5,769039,928+17%+<0.01% (now <0.01%)filing
2026-08-04Walter Matthew R.Officer (SVP, Chief HR Officer)F sell1,6750$85.39$143.0K34,159−5%−<0.01% (now <0.01%)filing
2026-08-04Thompson KweliOfficer (EVP & President, Neuroscience)A buy49,167 49,167 Ordinary Shares49,167filing
2026-08-04Thompson KweliOfficer (EVP & President, Neuroscience)A buy17,306 17,306 Ordinary Shares17,306filing
2026-08-04Thompson KweliOfficer (EVP & President, Neuroscience)A buy6,923035,390+24%+<0.01% (now <0.01%)filing
2026-08-04Thompson KweliOfficer (EVP & President, Neuroscience)F sell1,7390$85.39$148.5K28,467−6%−<0.01% (now <0.01%)filing
2026-08-04Pieton ThierryOfficer (EVP & Chief Financial Officer)A buy81,945 81,945 Ordinary Shares81,945filing
2026-08-04Pieton ThierryOfficer (EVP & Chief Financial Officer)A buy28,842 28,842 Ordinary Shares28,842filing
2026-08-04Pieton ThierryOfficer (EVP & Chief Financial Officer)A buy11,537049,645+30%+<0.01% (now <0.01%)filing
2026-08-04Quinn MichelleOfficer (EVP, GC and Secretary)A buy45,070 45,070 Ordinary Shares45,070filing
2026-08-04Quinn MichelleOfficer (EVP, GC and Secretary)A buy15,863 15,863 Ordinary Shares15,863filing
2026-08-04Quinn MichelleOfficer (EVP, GC and Secretary)A buy6,346026,721+31%+<0.01% (now <0.01%)filing
2026-08-04Martha GeoffreyDirector, Officer (Chairman and CEO)A buy273,150 273,150 Ordinary Shares273,150filing
2026-08-04Martha GeoffreyDirector, Officer (Chairman and CEO)A buy295,002 295,002 Ordinary Shares295,002filing
2026-08-04Martha GeoffreyDirector, Officer (Chairman and CEO)A buy103,831 103,831 Ordinary Shares103,831filing
2026-08-04Martha GeoffreyDirector, Officer (Chairman and CEO)A buy41,5330327,866+15%+<0.01% (now 0.03%)filing
2026-08-04Martha GeoffreyDirector, Officer (Chairman and CEO)F sell15,8100$85.39$1.35M286,333−5%−<0.01% (now 0.02%)filing
2026-08-04Marinaro MichaelOfficer (EVP, Pres MedSurg and Americas)A buy77,848 77,848 Ordinary Shares77,848filing
2026-08-04Marinaro MichaelOfficer (EVP, Pres MedSurg and Americas)A buy27,400 27,400 Ordinary Shares27,400filing
2026-08-04Marinaro MichaelOfficer (EVP, Pres MedSurg and Americas)A buy46,1470117,420+65%+<0.01% (now <0.01%)filing
2026-08-04Marinaro MichaelOfficer (EVP, Pres MedSurg and Americas)A buy10,960071,273+18%+<0.01% (now <0.01%)filing
2026-08-04Marinaro MichaelOfficer (EVP, Pres MedSurg and Americas)F sell3,3560$85.39$286.6K60,313−5%−<0.01% (now <0.01%)filing
2026-08-04KIIL HARRY SKIPOfficer (EVP & President Cardiovascular)A buy65,556 65,556 Ordinary Shares65,556filing
2026-08-04KIIL HARRY SKIPOfficer (EVP & President Cardiovascular)A buy23,074 23,074 Ordinary Shares23,074filing
2026-08-04KIIL HARRY SKIPOfficer (EVP & President Cardiovascular)A buy9,230043,669+27%+<0.01% (now <0.01%)filing
2026-08-04KIIL HARRY SKIPOfficer (EVP & President Cardiovascular)F sell3,0740$85.39$262.5K34,439−8%−<0.01% (now <0.01%)filing
2026-07-29Quinn MichelleOfficer (EVP, GC and Secretary)F sell2,0690$86.88$179.8K20,375−9%−<0.01% (now <0.01%)filing
2026-07-09Walter Matthew R.Officer (SVP, Chief HR Officer)S sell10b5-13,1020$83.15$257.9K35,694−8%−<0.01% (now <0.01%)filing
2026-06-09KIIL HARRY SKIPOfficer (EVP & President Cardiovascular)S sell2280$80.45$18.3K37,227−0.6%−<0.01% (now <0.01%)filing
2026-06-09KIIL HARRY SKIPOfficer (EVP & President Cardiovascular)S sell3,9610$80.44$318.6K37,455−10%−<0.01% (now <0.01%)filing
2026-06-08Walter Matthew R.Officer (SVP, Chief HR Officer)F sell2,8400$83.32$236.6K38,689−7%−<0.01% (now <0.01%)filing
2026-06-08Martha GeoffreyDirector, Officer (Chairman and CEO)F sell41,9360$83.32$3.49M301,163−12%−<0.01% (now 0.02%)filing
2026-06-08Marinaro MichaelOfficer (EVP, Pres MedSurg and Americas)F sell7,4710$83.32$622.5K63,122−11%−<0.01% (now <0.01%)filing
2026-06-08KIIL HARRY SKIPOfficer (EVP & President Cardiovascular)F sell6,8170$83.32$568.0K41,416−14%−<0.01% (now <0.01%)filing
2026-06-08Blomquist Denise L.Officer (Chief Accounting Officer)F sell2370$83.32$19.7K14,737−2%−<0.01% (now <0.01%)filing
2026-05-28Walter Matthew R.Officer (SVP, Chief HR Officer)M sell8,449 8,449 Ordinary Shares0filing
2026-05-28Walter Matthew R.Officer (SVP, Chief HR Officer)M buy9,149041,529+28%+<0.01% (now <0.01%)filing
2026-05-28Wall Brett A.Officer (EVP & Pres Neuroscience)M sell24,214 24,214 Ordinary Shares0filing
2026-05-28Wall Brett A.Officer (EVP & Pres Neuroscience)M buy26,907082,183+49%+<0.01% (now <0.01%)filing
2026-05-28Martha GeoffreyDirector, Officer (Chairman and CEO)M sell85,461 85,461 Ordinary Shares0filing
2026-05-28Martha GeoffreyDirector, Officer (Chairman and CEO)M buy94,9630343,099+38%+<0.01% (now 0.03%)filing
2026-05-28Marinaro MichaelOfficer (EVP, Pres MedSurg and Americas)M sell17,093 17,093 Ordinary Shares0filing
2026-05-28Marinaro MichaelOfficer (EVP, Pres MedSurg and Americas)M buy18,994070,593+37%+<0.01% (now <0.01%)filing
2026-05-28KIIL HARRY SKIPOfficer (EVP & President Cardiovascular)M sell14,517 14,517 Ordinary Shares0filing
2026-05-28KIIL HARRY SKIPOfficer (EVP & President Cardiovascular)M buy15,195048,233+46%+<0.01% (now <0.01%)filing
2026-05-28Blomquist Denise L.Officer (Chief Accounting Officer)M sell1,621 1,621 Ordinary Shares0filing
2026-05-28Blomquist Denise L.Officer (Chief Accounting Officer)M buy1,712014,974+13%+<0.01% (now <0.01%)filing
2026-05-04Walter Matthew R.Officer (SVP, Chief HR Officer)F sell350$80.00$2.8K32,380−0.1%−<0.01% (now <0.01%)filing
2026-04-29NABEL ELIZABETH GDirectorF sell2070$81.90$17.0K19,584−1%−<0.01% (now <0.01%)filing
2026-04-29NABEL ELIZABETH GDirectorA buy2,111019,791+12%+<0.01% (now <0.01%)filing
2026-04-29Powell Kendall JDirectorF sell2070$81.90$17.0K51,380−0.4%−<0.01% (now <0.01%)filing
2026-04-29Powell Kendall JDirectorA buy2,111051,587+4%+<0.01% (now <0.01%)filing
2026-04-29Lofton Kevin EDirectorF sell2070$81.90$17.0K10,140−2%−<0.01% (now <0.01%)filing
2026-04-29Lofton Kevin EDirectorA buy2,111010,347+26%+<0.01% (now <0.01%)filing
2026-04-29Lewis Gregory PDirectorF sell2070$81.90$17.0K5,754−3%−<0.01% (now <0.01%)filing
2026-04-29Lewis Gregory PDirectorA buy2,11105,961+55%+<0.01% (now <0.01%)filing
2026-04-29Lee Joon SupDirectorA buy1,80301,803new+<0.01% (now <0.01%)filing
2026-04-29Jellison William RDirectorA buy1,44406,444+29%+<0.01% (now <0.01%)filing
2026-04-29HOGAN RANDALL JDirectorF sell2070$81.90$17.0K48,998−0.4%−<0.01% (now <0.01%)filing
2026-04-29HOGAN RANDALL JDirectorA buy2,111049,205+4%+<0.01% (now <0.01%)filing
2026-04-29Groetelaars John PDirectorA buy1,44401,444new+<0.01% (now <0.01%)filing
2026-04-29Fonseca LidiaDirectorF sell2070$81.90$17.0K7,644−3%−<0.01% (now <0.01%)filing
2026-04-29Fonseca LidiaDirectorA buy2,11107,851+37%+<0.01% (now <0.01%)filing
2026-04-29DONNELLY SCOTT CDirectorF sell2070$81.90$17.0K23,679−0.9%−<0.01% (now <0.01%)filing
2026-04-29DONNELLY SCOTT CDirectorA buy2,111023,886+10%+<0.01% (now <0.01%)filing
2026-04-29Blomquist Denise L.Officer (Chief Accounting Officer)F sell3180$81.90$26.0K13,262−2%−<0.01% (now <0.01%)filing
2026-04-29Blomquist Denise L.Officer (Chief Accounting Officer)A buy1,508013,580+12%+<0.01% (now <0.01%)filing
2026-04-29ARNOLD CRAIGDirectorF sell2070$81.90$17.0K42,185−0.5%−<0.01% (now <0.01%)filing
2026-04-29ARNOLD CRAIGDirectorA buy2,111042,392+5%+<0.01% (now <0.01%)filing

Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.